company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 17:05:50+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7616000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 17:05:50+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7616000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 17:05:50+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 17:05:50+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7616000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 17:05:50+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3209000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 17:05:50+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14737000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 17:05:50+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17946000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 17:05:50+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-10330000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 17:05:50+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 17:05:50+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,137000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 17:05:50+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,137000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 17:05:50+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10193000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 17:05:50+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10193000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 17:05:50+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10193000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 17:05:50+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10193000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 17:05:50+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,44300000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 17:05:50+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.23
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 17:05:50+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,44300000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 17:05:50+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.23
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 17:05:50+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,44517000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 17:05:50+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.23
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 17:20:37+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12000000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 17:20:37+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12000000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 17:20:37+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 17:20:37+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12000000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 17:20:37+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3793000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 17:20:37+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,19197000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 17:20:37+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,22990000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 17:20:37+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-10990000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 17:20:37+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 17:20:37+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,126000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 17:20:37+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,126000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 17:20:37+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10864000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 17:20:37+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10864000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 17:20:37+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10864000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 17:20:37+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10864000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 17:20:37+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,45300000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 17:20:37+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.24
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 17:20:37+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,45300000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 17:20:37+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.24
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 17:20:37+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,44884000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 17:20:37+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.24
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:09:48+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5435000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:09:48+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5435000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:09:48+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5435000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:09:48+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3531000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:09:48+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13403000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:09:48+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16934000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:09:48+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11499000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:09:48+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,288000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:09:48+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-1240000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:09:48+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1528000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:09:48+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-13027000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:09:48+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13027000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:09:48+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13027000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:09:48+00:00,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,24000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:09:48+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-13051000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:09:48+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,45000000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:09:48+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.29
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:09:48+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,45000000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:09:48+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.29
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:09:48+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,0.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:09:48+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.29
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,2011-04-01,2011-06-30,2011-08-04 17:05:50+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3735000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,2011-04-01,2011-06-30,2011-08-04 17:05:50+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3735000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,2011-04-01,2011-06-30,2011-08-04 17:05:50+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,2011-04-01,2011-06-30,2011-08-04 17:05:50+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3735000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,2011-04-01,2011-06-30,2011-08-04 17:05:50+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4003000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,2011-04-01,2011-06-30,2011-08-04 17:05:50+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13975000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,2011-04-01,2011-06-30,2011-08-04 17:05:50+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17978000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,2011-04-01,2011-06-30,2011-08-04 17:05:50+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14243000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,2011-04-01,2011-06-30,2011-08-04 17:05:50+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1166000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,2011-04-01,2011-06-30,2011-08-04 17:05:50+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-862000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,2011-04-01,2011-06-30,2011-08-04 17:05:50+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2028000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,2011-04-01,2011-06-30,2011-08-04 17:05:50+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-16271000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,2011-04-01,2011-06-30,2011-08-04 17:05:50+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16271000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,2011-04-01,2011-06-30,2011-08-04 17:05:50+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16271000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,2011-04-01,2011-06-30,2011-08-04 17:05:50+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-16271000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,2011-04-01,2011-06-30,2011-08-04 17:05:50+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,45200000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,2011-04-01,2011-06-30,2011-08-04 17:05:50+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.36
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,2011-04-01,2011-06-30,2011-08-04 17:05:50+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,45200000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,2011-04-01,2011-06-30,2011-08-04 17:05:50+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.36
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,2011-04-01,2011-06-30,2011-08-04 17:05:50+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,45111000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,2011-04-01,2011-06-30,2011-08-04 17:05:50+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.36
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:47:03+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5249000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:47:03+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5249000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:47:03+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5249000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:47:03+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2953000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:47:03+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,15101000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:47:03+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:47:03+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18054000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:47:03+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12805000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:47:03+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1160000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:47:03+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-494000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:47:03+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1654000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:47:03+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14459000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:47:03+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14459000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:47:03+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14459000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:47:03+00:00,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,42000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:47:03+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-14501000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:47:03+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,45300000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:47:03+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.32
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:47:03+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,45300000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:47:03+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.32
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:47:03+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,45178000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:47:03+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.32
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5224000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5224000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5224000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1494000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14770000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16264000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11040000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1160000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-991000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2151000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-13191000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13191000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13191000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,-1000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q4,2011-10-01,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-13190000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q4,2011-10-01,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,45200000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q4,2011-10-01,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.29
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q4,2011-10-01,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,45200000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q4,2011-10-01,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.29
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q4,2011-10-01,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,45144000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q4,2011-10-01,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.29
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:04:02+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12221000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:04:02+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12221000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:04:02+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12221000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:04:02+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1697000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:04:02+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,15525000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:04:02+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:04:02+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17222000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:04:02+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5001000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:04:02+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1160000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:04:02+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,109000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:04:02+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1051000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:04:02+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6052000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:04:02+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6052000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:04:02+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6052000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:04:02+00:00,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,-9000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:04:02+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6043000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:04:02+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,46500000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:04:02+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.13
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:04:02+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,46500000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:04:02+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.13
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:04:02+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,47105000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:04:02+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.13
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:33:22+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4210000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:33:22+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4210000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:33:22+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4210000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:33:22+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1609000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:33:22+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12777000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:33:22+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:33:22+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14386000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:33:22+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-10176000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:33:22+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1160000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:33:22+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-940000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:33:22+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2100000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:33:22+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12276000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:33:22+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12276000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:33:22+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12276000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:33:22+00:00,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,9000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:33:22+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12285000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:33:22+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,49100000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:33:22+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.25
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:33:22+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,49100000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:33:22+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.25
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:33:22+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,49218000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 16:33:22+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.25
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:47:03+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5761000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:47:03+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5761000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:47:03+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5761000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:47:03+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1591000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:47:03+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12072000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:47:03+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,114000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:47:03+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,13777000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:47:03+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-8016000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:47:03+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1166000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:47:03+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-518000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:47:03+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1684000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:47:03+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9700000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:47:03+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9700000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:47:03+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9700000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:47:03+00:00,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,0.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:47:03+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9700000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:47:03+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,51100000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:47:03+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.19
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:47:03+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,51100000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:47:03+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.19
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:47:03+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,50661000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:47:03+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.19
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4101000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4101000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4101000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4233000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8786000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,18000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1759000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14796000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-10695000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1180000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,822000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-358000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11053000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11053000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11053000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,13000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11066000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,49500000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.22
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,49500000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.22
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,49474000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.22
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 16:04:02+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3554000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 16:04:02+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3554000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 16:04:02+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3554000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 16:04:02+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1382000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 16:04:02+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7411000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 16:04:02+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,77000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 16:04:02+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8870000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 16:04:02+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5316000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 16:04:02+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1180000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 16:04:02+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1990000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 16:04:02+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,810000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 16:04:02+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4506000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 16:04:02+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4506000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 16:04:02+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4506000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 16:04:02+00:00,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,12000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 16:04:02+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4518000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 16:04:02+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,50200000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 16:04:02+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.09
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 16:04:02+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,50200000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 16:04:02+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.09
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 16:04:02+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,51073000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 16:04:02+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.09
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 16:33:22+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,821000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 16:33:22+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,821000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 16:33:22+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,821000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 16:33:22+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1231000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 16:33:22+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11728000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 16:33:22+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,4000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 16:33:22+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12963000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 16:33:22+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12142000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 16:33:22+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1165000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 16:33:22+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1135000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 16:33:22+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-30000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 16:33:22+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12172000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 16:33:22+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12172000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 16:33:22+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12172000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 16:33:22+00:00,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,9000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 16:33:22+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12181000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 16:33:22+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,53000000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 16:33:22+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.23
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 16:33:22+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,53000000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 16:33:22+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.23
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 16:33:22+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,53468000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 16:33:22+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.23
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:13:10+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2389000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:13:10+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2389000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:13:10+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2389000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:13:10+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1579000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:13:10+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7735000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:13:10+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:13:10+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9314000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:13:10+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6925000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:13:10+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1191000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:13:10+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,115000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:13:10+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1076000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:13:10+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-8001000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:13:10+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8001000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:13:10+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8001000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:13:10+00:00,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,4000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:13:10+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8005000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:13:10+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,57200000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:13:10+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.14
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:13:10+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,57200000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:13:10+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.14
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:13:10+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,57124000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:13:10+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.14
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10567000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10567000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10567000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1028000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,15856000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,17000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16901000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6334000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1242000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2147000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,905000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5429000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5429000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5429000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,-2000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5427000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,54800000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.09
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,54800000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.09
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,55216000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.09
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:26:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3458000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:26:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3458000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:26:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3458000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:26:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1588000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:26:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9183000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:26:54+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,73000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:26:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10844000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:26:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7386000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:26:54+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1242000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:26:54+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-1509000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:26:54+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2751000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:26:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10137000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:26:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10137000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:26:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10137000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:26:54+00:00,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,2000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:26:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10139000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:26:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,59600000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:26:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.17
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:26:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,59600000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:26:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.17
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:26:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,59589000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:26:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.17
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:12:57+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3238000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:12:57+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3238000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:12:57+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:12:57+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3238000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:12:57+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1812000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:12:57+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13036000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:12:57+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:12:57+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14848000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:12:57+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11610000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:12:57+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1217000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:12:57+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,4096000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:12:57+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2879000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:12:57+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-8731000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:12:57+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8731000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:12:57+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8731000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:12:57+00:00,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,1000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:12:57+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8732000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:12:57+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,72800000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:12:57+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.12
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:12:57+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,71801000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:12:57+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.12
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:12:57+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,72800000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 16:12:57+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.12
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6912000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6912000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q4,2014-10-01,2014-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6911000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2048000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,18510000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-11576000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,33686000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-15156000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1314000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,4798000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-11619000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,454000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-26321000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-26321000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q4,2014-10-01,2014-12-31,,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,14649000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11672000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,132000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11804000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,66700000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.39
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,66773000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.39
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,66700000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.16
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 14:04:15+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6826000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 14:04:15+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6826000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 14:04:15+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,15000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 14:04:15+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,15000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 14:04:15+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6811000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 14:04:15+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4061000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 14:04:15+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,17120000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 14:04:15+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,60000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 14:04:15+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,21241000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 14:04:15+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14430000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 14:04:15+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1315000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 14:04:15+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,581000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 14:04:15+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-734000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 14:04:15+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-15164000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 14:04:15+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15164000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 14:04:15+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15164000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 14:04:15+00:00,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,-140000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 14:04:15+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-15024000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 14:04:15+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,71500000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 14:04:15+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.21
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 14:04:15+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,72341000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 14:04:15+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.21
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 14:04:15+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,71500000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 14:04:15+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.21
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:29:49+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,25842000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:29:49+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,25842000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:29:49+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:29:49+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,25842000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:29:49+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3534000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:29:49+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,16524000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:29:49+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,442000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:29:49+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,20500000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:29:49+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5342000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:29:49+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1306000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:29:49+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,865000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:29:49+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-441000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:29:49+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4901000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:29:49+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4901000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:29:49+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4901000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:29:49+00:00,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,102000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:29:49+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4799000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:29:49+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,72642000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:29:49+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.07
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:29:49+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,76760000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:29:49+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.06
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:29:49+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,68600000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:29:49+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.07
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 14:23:58+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10987000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 14:23:58+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10987000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 14:23:58+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1346000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 14:23:58+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1346000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 14:23:58+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9641000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 14:23:58+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2731000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 14:23:58+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,20067000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 14:23:58+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,5000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 14:23:58+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,22803000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 14:23:58+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-13162000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 14:23:58+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1241000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 14:23:58+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-218000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 14:23:58+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1459000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 14:23:58+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14621000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 14:23:58+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14621000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 14:23:58+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14621000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 14:23:58+00:00,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,-91000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 14:23:58+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-14530000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 14:23:58+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,72700000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 14:23:58+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.2
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 14:23:58+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,73262000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 14:23:58+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.2
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 14:23:58+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,72700000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 14:23:58+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.2
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4602000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4602000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q4,2015-10-01,2015-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,7000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,7000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4595000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2721000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,19047000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,21000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,21789000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-17194000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1338000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,397000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-941000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-18135000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18135000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18135000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,205000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-18340000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,73000000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.25
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,72901000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.24
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73000000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.25
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 15:02:04+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4820000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 15:02:04+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4820000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 15:02:04+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4820000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 15:02:04+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3212000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 15:02:04+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,20579000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 15:02:04+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,77000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 15:02:04+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,23868000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 15:02:04+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-19048000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 15:02:04+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1470000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 15:02:04+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-2314000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 15:02:04+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3784000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 15:02:04+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-22832000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 15:02:04+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22832000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 15:02:04+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22832000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 15:02:04+00:00,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,-254000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 15:02:04+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-22578000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 15:02:04+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,72800000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 15:02:04+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.31
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 15:02:04+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,73601000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 15:02:04+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.31
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 15:02:04+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,72800000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 15:02:04+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.31
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 14:03:39+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4787000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 14:03:39+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4787000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 14:03:39+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4787000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 14:03:39+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2724000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 14:03:39+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14166000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 14:03:39+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,27000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 14:03:39+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16917000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 14:03:39+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12130000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 14:03:39+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1421000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 14:03:39+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-2730000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 14:03:39+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4151000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 14:03:39+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-16281000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 14:03:39+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16281000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 14:03:39+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16281000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 14:03:39+00:00,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,2000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 14:03:39+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-16283000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 14:03:39+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,74000000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 14:03:39+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.22
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 14:03:39+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,73695000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 14:03:39+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.22
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 14:03:39+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,74000000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 14:03:39+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.22
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 15:14:11+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7763000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 15:14:11+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7763000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 15:14:11+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 15:14:11+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7763000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 15:14:11+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2756000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 15:14:11+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14105000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 15:14:11+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,143000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 15:14:11+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17004000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 15:14:11+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9241000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 15:14:11+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1465000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 15:14:11+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-822000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 15:14:11+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2287000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 15:14:11+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11528000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 15:14:11+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11528000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 15:14:11+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11528000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 15:14:11+00:00,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,24000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 15:14:11+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11552000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 15:14:11+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,72200000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 15:14:11+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.16
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 15:14:11+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,73734000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 15:14:11+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.16
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 15:14:11+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,72200000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 15:14:11+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.16
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8983000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8983000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q4,2016-10-01,2016-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2297000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2297000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6686000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2561000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12158000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,155000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14874000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-8188000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2131000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,5816000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,3685000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4503000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4503000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4503000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,34000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4537000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,73300000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.06
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,73699000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.06
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73300000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.06
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 15:02:04+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9437000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 15:02:04+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9437000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 15:02:04+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9437000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 15:02:04+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3058000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 15:02:04+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,16770000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 15:02:04+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,294000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 15:02:04+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,20122000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 15:02:04+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-10685000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 15:02:04+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2100000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 15:02:04+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-1434000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 15:02:04+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3534000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 15:02:04+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14219000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 15:02:04+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14219000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 15:02:04+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14219000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 15:02:04+00:00,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,-9000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 15:02:04+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-14210000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 15:02:04+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,74800000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 15:02:04+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.19
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 15:02:04+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,75167000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 15:02:04+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.19
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 15:02:04+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,74800000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 15:02:04+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.19
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 14:19:43+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3099000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 14:19:43+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3099000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 14:19:43+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3099000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 14:19:43+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2834000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 14:19:43+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,15759000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 14:19:43+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,22000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 14:19:43+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18615000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 14:19:43+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-15516000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 14:19:43+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2094000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 14:19:43+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,724000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 14:19:43+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1370000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 14:19:43+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-16886000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 14:19:43+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16886000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 14:19:43+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16886000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 14:19:43+00:00,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,12000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 14:19:43+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-16898000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 14:19:43+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,80500000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 14:19:43+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.21
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 14:19:43+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,80418000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 14:19:43+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.21
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 14:19:43+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,80500000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 14:19:43+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.21
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 15:15:34+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8760000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 15:15:34+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8760000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 15:15:34+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1142000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 15:15:34+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1142000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 15:15:34+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7618000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 15:15:34+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3343000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 15:15:34+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,17509000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 15:15:34+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,115000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 15:15:34+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,20967000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 15:15:34+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-13349000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 15:15:34+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2140000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 15:15:34+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,355000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 15:15:34+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1785000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 15:15:34+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-15134000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 15:15:34+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15134000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 15:15:34+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15134000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 15:15:34+00:00,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,2000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 15:15:34+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-15136000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 15:15:34+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,84100000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 15:15:34+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.18
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 15:15:34+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,83570000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 15:15:34+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.18
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 15:15:34+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,84100000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 15:15:34+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.18
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3890000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3890000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3890000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4698000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,16924000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,129000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,21751000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-17861000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2231000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,549000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1682000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-19543000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19543000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19543000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,226000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-19769000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,84600000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.2
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,84451000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.2
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,84600000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.2
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,2018-01-01,2018-03-31,2018-05-09 14:10:57+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3976000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,2018-01-01,2018-03-31,2018-05-09 14:10:57+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3976000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,2018-01-01,2018-03-31,2018-05-09 14:10:57+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3976000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,2018-01-01,2018-03-31,2018-05-09 14:10:57+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7609000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,2018-01-01,2018-03-31,2018-05-09 14:10:57+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,18441000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,2018-01-01,2018-03-31,2018-05-09 14:10:57+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,140000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,2018-01-01,2018-03-31,2018-05-09 14:10:57+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,26190000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,2018-01-01,2018-03-31,2018-05-09 14:10:57+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-22214000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,2018-01-01,2018-03-31,2018-05-09 14:10:57+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2221000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,2018-01-01,2018-03-31,2018-05-09 14:10:57+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-1342000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,2018-01-01,2018-03-31,2018-05-09 14:10:57+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3563000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,2018-01-01,2018-03-31,2018-05-09 14:10:57+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-25777000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,2018-01-01,2018-03-31,2018-05-09 14:10:57+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-25777000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,2018-01-01,2018-03-31,2018-05-09 14:10:57+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-25777000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,2018-01-01,2018-03-31,2018-05-09 14:10:57+00:00,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,233000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,2018-01-01,2018-03-31,2018-05-09 14:10:57+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-26010000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,2018-01-01,2018-03-31,2018-05-09 14:10:57+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,100000000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,2018-01-01,2018-03-31,2018-05-09 14:10:57+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.26
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,2018-01-01,2018-03-31,2018-05-09 14:10:57+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,98592000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,2018-01-01,2018-03-31,2018-05-09 14:10:57+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.26
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,2018-01-01,2018-03-31,2018-05-09 14:10:57+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,100000000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,2018-01-01,2018-03-31,2018-05-09 14:10:57+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.26
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,2018-04-01,2018-06-30,2018-08-09 14:19:43+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12494000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,2018-04-01,2018-06-30,2018-08-09 14:19:43+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12494000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,2018-04-01,2018-06-30,2018-08-09 14:19:43+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12494000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,2018-04-01,2018-06-30,2018-08-09 14:19:43+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9492000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,2018-04-01,2018-06-30,2018-08-09 14:19:43+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,21010000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,2018-04-01,2018-06-30,2018-08-09 14:19:43+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,243000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,2018-04-01,2018-06-30,2018-08-09 14:19:43+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,30745000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,2018-04-01,2018-06-30,2018-08-09 14:19:43+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-18251000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,2018-04-01,2018-06-30,2018-08-09 14:19:43+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2195000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,2018-04-01,2018-06-30,2018-08-09 14:19:43+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2000000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,2018-04-01,2018-06-30,2018-08-09 14:19:43+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-195000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,2018-04-01,2018-06-30,2018-08-09 14:19:43+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-18446000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,2018-04-01,2018-06-30,2018-08-09 14:19:43+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18446000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,2018-04-01,2018-06-30,2018-08-09 14:19:43+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18446000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,2018-04-01,2018-06-30,2018-08-09 14:19:43+00:00,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,-24000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,2018-04-01,2018-06-30,2018-08-09 14:19:43+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-18422000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,2018-04-01,2018-06-30,2018-08-09 14:19:43+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,97000000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,2018-04-01,2018-06-30,2018-08-09 14:19:43+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.19
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,2018-04-01,2018-06-30,2018-08-09 14:19:43+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,98787000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,2018-04-01,2018-06-30,2018-08-09 14:19:43+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.19
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,2018-04-01,2018-06-30,2018-08-09 14:19:43+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,97000000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,2018-04-01,2018-06-30,2018-08-09 14:19:43+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.19
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,2018-07-01,2018-09-30,2018-11-08 15:15:34+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1454000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,2018-07-01,2018-09-30,2018-11-08 15:15:34+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1454000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,2018-07-01,2018-09-30,2018-11-08 15:15:34+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,2018-07-01,2018-09-30,2018-11-08 15:15:34+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1454000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,2018-07-01,2018-09-30,2018-11-08 15:15:34+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7923000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,2018-07-01,2018-09-30,2018-11-08 15:15:34+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,22006000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,2018-07-01,2018-09-30,2018-11-08 15:15:34+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,18000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,2018-07-01,2018-09-30,2018-11-08 15:15:34+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,29947000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,2018-07-01,2018-09-30,2018-11-08 15:15:34+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-28493000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,2018-07-01,2018-09-30,2018-11-08 15:15:34+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2346000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,2018-07-01,2018-09-30,2018-11-08 15:15:34+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1242000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,2018-07-01,2018-09-30,2018-11-08 15:15:34+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1104000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,2018-07-01,2018-09-30,2018-11-08 15:15:34+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-29597000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,2018-07-01,2018-09-30,2018-11-08 15:15:34+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-29597000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,2018-07-01,2018-09-30,2018-11-08 15:15:34+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-29597000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,2018-07-01,2018-09-30,2018-11-08 15:15:34+00:00,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,-42000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,2018-07-01,2018-09-30,2018-11-08 15:15:34+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-29555000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,2018-07-01,2018-09-30,2018-11-08 15:15:34+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,105600000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,2018-07-01,2018-09-30,2018-11-08 15:15:34+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.28
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,2018-07-01,2018-09-30,2018-11-08 15:15:34+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,105410000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,2018-07-01,2018-09-30,2018-11-08 15:15:34+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.28
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,2018-07-01,2018-09-30,2018-11-08 15:15:34+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,105600000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,2018-07-01,2018-09-30,2018-11-08 15:15:34+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.28
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2729000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2729000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2729000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4490000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,23431000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,70000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,27991000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-25262000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2414000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,244000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2170000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-27432000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-27432000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-27432000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,-113000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-27319000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,103400000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.25
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,103185000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.25
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,103400000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.25
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 17:41:36+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5887000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 17:41:36+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5887000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 17:41:36+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1399000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 17:41:36+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1399000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 17:41:36+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4488000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 17:41:36+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6238000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 17:41:36+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,27493000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 17:41:36+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,87000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 17:41:36+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,33818000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 17:41:36+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-29330000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 17:41:36+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2726000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 17:41:36+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1002000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 17:41:36+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1724000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 17:41:36+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-31054000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 17:41:36+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-31054000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 17:41:36+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-31054000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 17:41:36+00:00,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,-208000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 17:41:36+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-30846000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 17:41:36+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,110200000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 17:41:36+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.28
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 17:41:36+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,110167000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 17:41:36+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.28
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 17:41:36+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,110200000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 17:41:36+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.28
